Transplant Recipient (Kidney)

Nephrology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genentech
GenentechCA - Oceanside
1 program
Steroid-Free Maintenance ImmunosuppressionN/A1 trial
Active Trials
NCT01277770Completed7,500Est. May 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GenentechSteroid-Free Maintenance Immunosuppression

Clinical Trials (1)

Total enrollment: 7,500 patients across 1 trials

NCT01277770GenentechSteroid-Free Maintenance Immunosuppression

Studies of Kidney Transplant Outcome

Start: May 2009Est. completion: May 20197,500 patients
N/ACompleted

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space